Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ipomoea cairica ethyl acetate extract
- Development stage
- Preclinical
- Lead developer
- Central University of Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ipomoea cairica ethyl acetate extract is a botanical extract derived from the stems and leaves of *Ipomoea cairica* (commonly known as mile-a-minute vine or morning glory). The extract contains various bioactive phytochemicals, including alkaloids, saponins, phenols, flavonoids, phytosterols, tannins, triterpenoids, and anthraquinones. It has been investigated for its significant antioxidant and antiproliferative activities, particularly against breast cancer cell lines such as MCF-7, MDA-MB-231, and the triple-negative breast cancer line 4T1. Additionally, the ethyl acetate fraction of *Ipomoea cairica* has demonstrated potential antidiabetic activity through the inhibition of alpha-glucosidase and alpha-amylase enzymes.
- Other names
- Ipomoea cairica ethyl acetate extractIpomoea cairica ethyl acetate fraction
02
Targets
AMY (Pancreatic alpha-amylase)PTPN1 (Protein tyrosine phosphatase 1B)Sucrase-Isomaltase
Beyond the preview
Go deeper on ipomoea cairica ethyl acetate extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ipomoea cairica ethyl acetate extract.